Sarah D Atkinson MD

Psychiatry•Rochester, NY

Child & Adolescent Psychiatry

Physician

Join to View Full Profile

885 Winton Rd SRochester, NY 14618
Phone+1 585-241-9670
Fax+1 585-241-3243

Education & Training

Menninger School of PsychiatryFellowship, Child and Adolescent Psychiatry, 1992 - 1994
University of Oklahoma Health Sciences CenterResidency, Psychiatry, 1989 - 1992
University of Oklahoma Health Sciences CenterResidency, Surgery, 1987 - 1989
University of Oklahoma College of MedicineClass of 1987

Certifications & Licensure

NY State Medical License 1995 - 2025
OK State Medical License 1988 - 1992
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Start of enrollment: 2011 Jun 01
Completed
Phase 3
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Start of enrollment: 2011 Sep 01
Completed
Phase 3
PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01
Completed
Phase 3
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Start of enrollment: 2012 Jun 01
Completed
Phase 3
Pediatric Schizophrenia Efficacy and Safety Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD) Start of enrollment: 2013 Oct 01
Completed
Phase 2
Pediatric Open-Label Extension Study Start of enrollment: 2013 Sep 30
Completed
Phase 3
Lurasidone Pediatric Bipolar Study Start of enrollment: 2014 Mar 01
Completed
Phase 3
Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension Start of enrollment: 2019 Oct 04
Completed
Phase 2
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen® Start of enrollment: 2014 Jun 01
Terminated
Phase 2, Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

3 citations
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies.
Bryan Dirks, Maurizio Fava, Sarah D Atkinson, Mark Joyce, Michael E Thase
Psychopharmacology Bulletin. 2022-10-27
26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Mo...
Sarah Atkinson, Mary Bachinsky, Yaron Raiter, Paula Abreu, Claudia Ianos
Journal of Child and Adolescent Psychopharmacology. 2022-10-01
5 citations
Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replicat...
Robert L Findling, Sarah Atkinson, Mary Bachinsky, Yaron Raiter, Paula Abreu
Journal of Child and Adolescent Psychopharmacology. 2022-04-01